GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CVM-1118 | TRX 818 | TRX-818
Compound class:
Synthetic organic
Comment: Foslinanib (CVM-1118) is an orally bioavailable protein kinase inhibitor with antiangiogenic and antineoplastic activities [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| [2-(3-fluorophenyl)-6-methoxy-4-oxo-1H-quinolin-5-yl] dihydrogen phosphate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10721 | foslinanib |
Synonyms ![]() |
| CVM-1118 | TRX 818 | TRX-818 |
Database Links ![]() |
|
| CAS Registry No. | 1256037-60-1 (source: WHO INN record) |
| GtoPdb PubChem SID | 442878655 |
| PubChem CID | 49840582 |
| Search Google for chemical match using the InChIKey | ZDWFMAHQGDEALT-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | ZDWFMAHQGDEALT |
| Search PubMed clinical trials | foslinanib |
| Search PubMed titles | foslinanib |
| Search PubMed titles/abstracts | foslinanib |
| UniChem Compound Search for chemical match using the InChIKey | ZDWFMAHQGDEALT-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZDWFMAHQGDEALT-UHFFFAOYSA-N |